Pharma Foods International Co., Ltd. Logo

Pharma Foods International Co., Ltd.

Researches and sells functional ingredients and direct-to-consumer health & beauty products.

2929 | T

Overview

Corporate Details

ISIN(s):
JP3802310007
LEI:
Country:
Japan
Address:
京都市西京区御陵大原1番地49
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Pharma Foods International Co., Ltd. develops and sells functional food ingredients and related consumer products. The company operates through two main segments: a functional materials business and a direct-to-consumer (B2C) business. The functional materials division researches and develops unique, science-backed ingredients with a focus on areas such as immunity, aging, and the nervous system. The B2C segment utilizes these proprietary ingredients in its e-commerce and wholesale distribution of supplements, cosmetics, and non-pharmaceutical products. Guided by a mission to create food products with pharmaceutical-like efficacy, the company aims to promote health and improve quality of life, and is also engaged in biomedical drug discovery.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-10-21 08:34
Registration Form
確認書
Japanese 8.2 KB
2025-10-21 08:32
Annual Report
有価証券報告書-第28期(2024/08/01-2025/07/31)
Japanese 1.4 MB
2025-06-05 08:32
Transaction in Own Shares
自己株券買付状況報告書(法24条の6第1項に基づくもの)
Japanese 22.2 KB
2025-03-14 05:31
Report Publication Announcement
確認書
Japanese 8.2 KB
2025-03-14 05:30
Interim Report
半期報告書-第28期(2024/08/01-2025/07/31)
Japanese 292.0 KB
2024-11-18 07:36
Share Issue/Capital Change
臨時報告書
Japanese 29.9 KB
2024-10-28 07:43
Registration Form
訂正有価証券届出書(参照方式)
Japanese 50.6 KB
2024-10-28 07:35
Post-Annual General Meeting Information
臨時報告書
Japanese 28.6 KB
2024-10-24 08:35
Registration Form
訂正有価証券届出書(参照方式)
Japanese 51.3 KB
2024-10-24 08:33
Registration Form
確認書
Japanese 8.2 KB
2024-10-24 08:32
Governance Information
内部統制報告書-第27期(2023/08/01-2024/07/31)
Japanese 22.7 KB
2024-10-24 08:30
Annual Report
有価証券報告書-第27期(2023/08/01-2024/07/31)
Japanese 1.4 MB
2024-10-22 07:50
Registration Form
有価証券届出書(参照方式)
Japanese 64.0 KB
2024-06-14 06:03
Report Publication Announcement
確認書
Japanese 8.2 KB
2024-06-14 06:02
Quarterly Report
四半期報告書-第27期第3四半期(2024/02/01-2024/04/30)
Japanese 184.3 KB

Automate Your Workflow. Get a real-time feed of all Pharma Foods International Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Pharma Foods International Co., Ltd.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Pharma Foods International Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

C4 Therapeutics, Inc. Logo
Developing protein degrader medicines to treat cancer and other serious diseases.
United States of America
CCCC
Cabaletta Bio, Inc. Logo
Develops engineered T cell therapies for a curative reset in autoimmune diseases.
United States of America
CABA
Cadrenal Therapeutics, Inc. Logo
Developing novel anticoagulant therapies for high-risk cardiovascular patients.
United States of America
CVKD
CalciMedica, Inc. Logo
Develops CRAC channel inhibitors for critical illnesses like acute pancreatitis & AKI.
United States of America
CALC
Calidi Biotherapeutics, Inc. Logo
Develops immunotherapies using stem cells to deliver oncolytic viruses against solid tumors.
United States of America
CLDI
Calliditas Therapeutics Logo
Develops and commercializes novel treatments for rare renal and hepatic diseases like IgA nephropathy.
Sweden
CALTX
CALTH. Inc Logo
Develops AI-powered rapid diagnostic solutions for point-of-care and self-testing.
South Korea
402420
CAMBRIDGE NUTRITIONAL SCIENCES PLC Logo
Develops and manufactures diagnostic tests for food sensitivity and gut health.
United Kingdom
CNSL
Camp4 Therapeutics Corp Logo
Developing RNA-based therapies to upregulate genes for rare metabolic and CNS disorders.
United States of America
CAMP
Camurus Logo
Develops long-acting medicines for severe chronic diseases using advanced drug delivery.
Sweden
CAMX

Talk to a Data Expert

Have a question? We'll get back to you promptly.